Recombinant SARS-CoV-2 spike protein stimulates secretion of chymase, tryptase, and IL-1β from human mast cells, augmented by IL-33
I Tsilioni, TC Theoharides - International Journal of Molecular Sciences, 2023 - mdpi.com
International Journal of Molecular Sciences, 2023•mdpi.com
SARS-CoV-2 infects cells via its spike (S) protein binding to its surface receptor angiotensin-
converting enzyme 2 (ACE2) and results in the production of multiple proinflammatory
cytokines, especially in the lungs, leading to what is known as COVID-19. However, the cell
source and the mechanism of secretion of such cytokines have not been adequately
characterized. In this study, we used human cultured mast cells that are plentiful in the lungs
and showed that recombinant SARS-CoV-2 full-length S protein (1–10 ng/mL), but not its …
converting enzyme 2 (ACE2) and results in the production of multiple proinflammatory
cytokines, especially in the lungs, leading to what is known as COVID-19. However, the cell
source and the mechanism of secretion of such cytokines have not been adequately
characterized. In this study, we used human cultured mast cells that are plentiful in the lungs
and showed that recombinant SARS-CoV-2 full-length S protein (1–10 ng/mL), but not its …
SARS-CoV-2 infects cells via its spike (S) protein binding to its surface receptor angiotensin-converting enzyme 2 (ACE2) and results in the production of multiple proinflammatory cytokines, especially in the lungs, leading to what is known as COVID-19. However, the cell source and the mechanism of secretion of such cytokines have not been adequately characterized. In this study, we used human cultured mast cells that are plentiful in the lungs and showed that recombinant SARS-CoV-2 full-length S protein (1–10 ng/mL), but not its receptor-binding domain (RBD), stimulates the secretion of the proinflammatory cytokine interleukin-1β (IL-1β) as well as the proteolytic enzymes chymase and tryptase. The secretion of IL-1β, chymase, and tryptase is augmented by the co-administration of interleukin-33 (IL-33) (30 ng/mL). This effect is mediated via toll-like receptor 4 (TLR4) for IL-1β and via ACE2 for chymase and tryptase. These results provide evidence that the SARS-CoV-2 S protein contributes to inflammation by stimulating mast cells through different receptors and could lead to new targeted treatment approaches.
![](/scholar/images/qa_favicons/mdpi.com.png)